Page last updated: 2024-11-02

pentoxifylline and Granulocytic Leukemia, Chronic

pentoxifylline has been researched along with Granulocytic Leukemia, Chronic in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Pentoxifylline was added after incubation of normal cells with patient serum, and the directed chemotaxis was restored."1.28Pentoxifylline in vitro reverses neutrophil chemotactic deficiency induced by interleukin-2 treatment. ( Fossat, C; Juhan-Vague, I; Maraninchi, D; Sainty, D; Stoppa, AM, 1992)
"Pentoxifylline (PTX) is a non-toxic methylxanthine used clinically for the treatment of intermittent claudication."1.28Amelioration of doxorubicin resistance by pentoxifylline in human chronic myeloid leukemia cells in vitro. ( Advani, S; Chitnis, M; Juvekar, A; Viladkar, A, 1991)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kido, M1
Tago, O1
Fujiwara, H1
Ito, M1
Niwano, H1
Fossat, C1
Sainty, D1
Stoppa, AM1
Maraninchi, D1
Juhan-Vague, I1
Viladkar, A1
Juvekar, A1
Chitnis, M1
Advani, S1

Other Studies

3 other studies available for pentoxifylline and Granulocytic Leukemia, Chronic

ArticleYear
Leg ulcer associated with hydroxyurea treatment in a patient with chronic myelogenous leukaemia: successful treatment with prostagladin E1 and pentoxifylline.
    The British journal of dermatology, 1998, Volume: 139, Issue:6

    Topics: Alprostadil; Antineoplastic Agents; Humans; Hydroxyurea; Leg Ulcer; Leukemia, Myelogenous, Chronic,

1998
Pentoxifylline in vitro reverses neutrophil chemotactic deficiency induced by interleukin-2 treatment.
    Nouvelle revue francaise d'hematologie, 1992, Volume: 34 Suppl

    Topics: Bacteremia; Bone Marrow Transplantation; Cells, Cultured; Chemotaxis, Leukocyte; Disease Susceptibil

1992
Amelioration of doxorubicin resistance by pentoxifylline in human chronic myeloid leukemia cells in vitro.
    Selective cancer therapeutics, 1991,Fall, Volume: 7, Issue:3

    Topics: Doxorubicin; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Leukemia, Myelogeno

1991